Amgen’s Repatha clears blocked arteries, shows study

Amgen has presented clinical data indicating that its PCSK9 inhibitor Repatha could help to reverse heart disease by removing atherosclerotic plaques, showing for the first time that the effect of thi…
Read the full story: PharmaTimes: News RSS